State and trait abnormalities in serotonin function in major depression
- 2 January 2002
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 180 (1) , 24-28
- https://doi.org/10.1192/bjp.180.1.24
Abstract
Background: Neuroendocrine studies of brain serotonin (5-HT) function in depression generally show evidence of impaired 5-HT function but it is disputed whether or not this impairment resolves with clinical recovery.Aims: To use the endocrine response to the selective 5-HTreuptake inhibitor, citalopram, to study brain 5-HT function in acute and recovered depressed subjects relative to healthy controls.Method: We used a double-blind, placebo-controlled design to measure the prolactin and cortisol responses to citalopram (10 mg intravenously) in patients with major depression, in unmedicated subjects recovered from depression and in healthy controls.Results: The prolactin responses to citalopram were blunted similarly in both acutely depressed and recovered subjects. The cortisol responses were blunted in the acutely depressed patients but not in the recovered subjects.Conclusions: Our data support the proposal that some aspects of impaired 5-HT neurotransmission may be trait markers of vulnerability to depression. The recovery of the cortisol response to citalopram may indicate resolution of hypothalamic – pituitary-adrenal axis dysfunction.Keywords
This publication has 24 references indexed in Scilit:
- [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorderBiological Psychiatry, 2000
- The citalopram challenge test in patients with major depression and in healthy controlsPsychiatry Research, 1999
- Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomographyBiological Psychiatry, 1998
- Neuroendocrine Effects of a 20-mg Citalopram Infusion in Healthy Males A Placebo-Controlled Evaluation of Citalopram as 5-HT Function ProbeNeuropsychopharmacology, 1996
- Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patientsBiological Psychiatry, 1993
- Decreased 5-HT-Mediated Prolactin Release in Major DepressionThe British Journal of Psychiatry, 1992
- Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormalityJournal of Affective Disorders, 1991
- Diminished prolactin responses to repeated fenfluramine challenge in manPsychiatry Research, 1987
- Rank Transformations as a Bridge Between Parametric and Nonparametric StatisticsThe American Statistician, 1981
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960